Beta-Lactamase Gene Expression Level of Hospital-Acquired CRAB Isolated from Children in Picu

References

• JohnsonJ, RobinsonG, ZhaoL, HarrisA, StineO, ThomK. Comparison of molecular typing methods for the analyses of Acinetobacter baumannii from ICU patients. Diagn Microbiol Infect Dis. 2016;86(4):345–350. doi:10.1016/j.diagmicrobio.2016.08.02427640081
   PubMed Web of Science ®Google Scholar
• SalehiB, GhalavandZ, MohammadzadehM, MalekiD, KodoriM, KadkhodaH. Clonal relatedness and resistance characteristics of OXA-24 and −58 producing carbapenem-resistant Acinetobacter baumannii isolates in Tehran, Iran. J Appl Microbiol. 2019;127(5):1421–1429. doi:10.1111/jam.1440931400237
   PubMed Web of Science ®Google Scholar
• BaranG, ErbayA, BodurH, et al. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections. Int J Infect Dis. 2008;12(1):16–21. doi:10.1016/j.ijid.2007.03.00517513154
   PubMed Web of Science ®Google Scholar
• DizbayM, TunccanO, SezerB, HizelK. Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors. Scand J Infect Dis. 2010;42(10):741–746. doi:10.3109/00365548.2010.48956820500117
   PubMed Web of Science ®Google Scholar
• HuF, GuoY, ZhuD, et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014. Clin Microbiol Infect. 2016;22:S9–14. doi:10.1016/j.cmi.2016.01.00127000156
   PubMed Web of Science ®Google Scholar
• MeraR, MillerL, Amrine-MadsenH, SahmD. Acinetobacter baumannii 2002–2008: increase of carbapenem-associated multiclass resistance in the United States. Microbial Drug Resistance (Larchmont, NY). 2010;16(3):209–215. doi:10.1089/mdr.2010.0052
   PubMed Web of Science ®Google Scholar
• AyobamiO, WillrichN, HarderT, OkekeI, EckmannsT, MarkwartR. Acinetobacter baumanniiThe incidence and prevalence of hospital-acquired (carbapenem-resistant) in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis. Emerg Microbes Infect. 2019;8(1):1747–1759. doi:10.1080/22221751.2019.169827331805829
   PubMedGoogle Scholar
• KimY, KimS, HongK, KimY, ParkY, KangM. Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: impact of appropriate antimicrobial therapy. J Korean Med Sci. 2012;27(5):471–475. doi:10.3346/jkms.2012.27.5.47122563209
   PubMed Web of Science ®Google Scholar
• ChoeY, LeeH, ChoiE. Acinetobacter baumanniirisk factors for mortality in children with bacteremia in south korea: the role of carbapenem resistance. Microbial Drug Resistance (Larchmont, NY). 2019;25(8):1210–1218. doi:10.1089/mdr.2018.0465
   Web of Science ®Google Scholar
• KatragkouA, KotsiouM, AntachopoulosC, et al. Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: a case-control study. Intensive Care Med. 2006;32(9):1384–1391. doi:10.1007/s00134-006-0239-x16788807
   PubMed Web of Science ®Google Scholar
• HsuA, TammaP. Treatment of multidrug-resistant Gram-negative infections in children. Clin Infect Dis. 2014;58(10):1439–1448. doi:10.1093/cid/ciu06924501388
   PubMed Web of Science ®Google Scholar
• AbbasW, AcharyaR, PanditA, GuptaS, RaoR. The real-world experience with nivolumab in previously treated patients with advanced non-small cell lung cancer from a cancer center in India. South Asian J Cancer. 2020;9(1):50–52. doi:10.4103/sajc.sajc_111_1931956623
   PubMed Web of Science ®Google Scholar
• AaronsL, RowlandM. Kinetics of drug displacement interactions. J Pharmacokinet Biopharm. 1981;9(2):181–190. doi:10.1007/BF10680817277208
   PubMedGoogle Scholar
• MartinezT, MartinezI, VazquezG, AquinoE, RobledoI. Genetic environment of the KPC gene in Acinetobacter baumannii ST2 clone from Puerto Rico and genomic insights into its drug resistance. J Med Microbiol. 2016;65(8):784–792. doi:10.1099/jmm.0.00028927259867
   PubMed Web of Science ®Google Scholar
• KarampatakisT, TsergouliK, PolitiL, et al. Polyclonal predominance of concurrently producing OXA-23 and OXA-58 carbapenem-resistant Acinetobacter baumannii strains in a pediatric intensive care unit. Mol Biol Rep. 2019;46(3):3497–3500. doi:10.1007/s11033-019-04744-430989561
   PubMed Web of Science ®Google Scholar
• FroeseM. [Significance of current life conflicts for psychological disorders]. Z Arztl Fortbild (Jena). 1985;79(4):167–170. Geraman3993105
   PubMedGoogle Scholar
• da SilvaK, MacielW, CrodaJ, et al. A high mortality rate associated with multidrug-resistant Acinetobacter baumannii ST79 and ST25 carrying OXA-23 in a Brazilian intensive care unit. PLoS One. 2018;13(12):e0209367. doi:10.1371/journal.pone.020936730592758
   PubMed Web of Science ®Google Scholar
• HoranT, AndrusM, DudeckM. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–332. doi:10.1016/j.ajic.2008.03.00218538699
   PubMed Web of Science ®Google Scholar
• CalandraT, CohenJ. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med. 2005;33(7):1538–1548. doi:10.1097/01.CCM.0000168253.91200.8316003060
   PubMed Web of Science ®Google Scholar
• SingerM, DeutschmanC, SeymourC, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.028726903338
   PubMed Web of Science ®Google Scholar
• AroraNK. Rational use of antibiotics for pneumonia. Indian Pediatr. 2010;47(1):11–18. doi:10.1007/s13312-010-0015-420139472
   PubMed Web of Science ®Google Scholar
• SartelliM, CatenaF, Abu-ZidanF, et al. Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference. World J Emergency Surgery. 2017;12:22.
   PubMed Web of Science ®Google Scholar
• BrouwerM, TunkelA, van de BeekD. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010;23(3):467–492.20610819
   PubMed Web of Science ®Google Scholar
• GriefS, LozaJ. Guidelines for the evaluation and treatment of pneumonia. Prim Care. 2018;45(3):485–503. doi:10.1016/j.pop.2018.04.00130115336
   PubMed Web of Science ®Google Scholar
• SimõesE, SilvaA, OliveiraE, MakR. Urinary tract infection in pediatrics: an overview. J Pediatr (Rio J). 2020;96:65–79. doi:10.1016/j.jped.2019.10.00631783012
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twenty-fourth informational supplement; 2014. M100S, 24th Edition.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twenty-fifth informational supplement; 2015. M100S, 25th Edition.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twenty-sixth informational supplement; 2016. M100S, 26th Edition.
   Google Scholar
• Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing[S]. Twenty-seventh informational supplement; 2017. M100S, 27th Edition.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twenty-eighth informational supplement; 2018. M100S, 28th Edition.
   Google Scholar
• PrasadP, SunJ, DannerR, NatansonC. Excess deaths associated with tigecycline after approval based on noninferiority trials. Clin Infect Dis. 2012;54(12):1699–1709. doi:10.1093/cid/cis27022467668
   PubMed Web of Science ®Google Scholar
• PunpanichW, NithitamsakunN, TreeratweeraphongV, SuntarattiwongP. Risk factors for carbapenem non-susceptibility and mortality in Acinetobacter baumannii bacteremia in children. Int j Infect Dis. 2012;16(11):e811–815. doi:10.1016/j.ijid.2012.07.00622898148
   PubMed Web of Science ®Google Scholar
• XiaJ, ZhangD, XuY, GongM, ZhouY, FangX. A retrospective analysis of carbapenem-resistant Acinetobacter baumannii-mediated nosocomial pneumonia and the in vitro therapeutic benefit of cefoperazone/sulbactam. Int J Infect Dis. 2014;23:90–93. doi:10.1016/j.ijid.2014.01.01724726664
   PubMed Web of Science ®Google Scholar
• NiuT, LuoQ, LiY, ZhouY, YuW, XiaoY. Acinetobacter baumanniiComparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant. Antimicrob Resist Infect Control. 2019;8:52. doi:10.1186/s13756-019-0502-x30886705
   PubMed Web of Science ®Google Scholar
• KiratisinP, ApisarnthanarakA, KaewdaengS. Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates. Int J Antimicrob Agents. 2010;36(3):243–246. doi:10.1016/j.ijantimicag.2010.04.01120541913
   PubMed Web of Science ®Google Scholar
• NovelliA, AdembriC, LiviP, FallaniS, MazzeiT, De GaudioA. Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis. Clin Pharmacokinet. 2005;44(5):539–549. doi:10.2165/00003088-200544050-0000715871639
   PubMed Web of Science ®Google Scholar
• MugnierP, PoirelL, NaasT, NordmannP. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis. 2010;16(1):35–40. doi:10.3201/eid1601.09085220031040
   PubMed Web of Science ®Google Scholar
• LiuL, JiS, RuanZ, et al. Dissemination of blaOXA-23 in Acinetobacter spp. in China: main roles of conjugative plasmid pAZJ221 and transposon Tn2009. Antimicrob Agents Chemother. 2015;59(4):1998–2005. doi:10.1128/AAC.04574-1425605357
   PubMed Web of Science ®Google Scholar
• YangY, XuQ, LiT, et al. OXA-23 is a prevalent mechanism contributing to sulbactam resistance in diverse acinetobacter baumannii clinical strains. Antimicrob Agents Chemother. 2019;63(1). doi:10.1128/AAC.01676-18.
   Web of Science ®Google Scholar
• SchuertzK, TuonF, PalmeiroJ, et al. Bacteremia and meningitis caused by OXA-23-producing Acinetobacter baumannii - molecular characterization and susceptibility testing for alternative antibiotics. Brazilian J Microbiol. 2018;49:199–204. doi:10.1016/j.bjm.2018.04.002
   Web of Science ®Google Scholar